Product ID |
Product Name |
CAS# |
Purity |
Y3309111 |
methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine hydrochloride |
947316-47-4 |
95% |
Y3296607 |
N-[(4-chlorophenyl)methyl]-N-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]pyridine-3-sulfonamide |
1021106-40-0 |
99% |
Y3286873 |
CXCR7 modulator 1 |
2231812-31-8 |
99% |
Y3310697 |
Caesappanin C |
1913319-59-1 |
98% |
Y3307828 |
5-MethoxyPinocembroside |
1450878-89-3 |
95% |
Y3308325 |
10-Isobutyryloxy-8,9-epoxythymol isobutyrate |
22518-06-5 |
98% |
Y3310718 |
(Rac)-VU 6008667 |
2092917-63-8 |
98% |
Y3238151 |
3-Cyclopropyl-2-methoxypyridine |
1414870-59-9 |
95% |
Y3246294 |
4-Isopropoxy-1-methoxy-2-methylbenzene |
1369793-72-5 |
95% |
Y3247408 |
(S)-Mapracorat |
887375-15-7 |
99% |
Y3295340 |
PROTAC B-Raf degrader 1 |
2364367-27-9 |
99% |
Y3290156 |
PROTAC MDM2 Degrader-3 |
2249750-23-8 |
96% |
Y3307681 |
GLP-1(7-37) acetate |
1450806-98-0 |
98% |
Y1253726 |
Pomalidomide-PEG3-C2-NH2 TFA |
2414913-97-4 |
97% |
Y3269059 |
2,5-Dibromo-3-methoxybenzaldehyde |
856767-02-7 |
95% |
Y3238427 |
PROTAC SGK3 degrader-1 |
2381320-35-8 |
99% |
Y3244695 |
MC-VC-PABC-Aur0101 |
1438849-92-3 |
98% |
Y3238646 |
(2R,3S)-E1R |
1424832-60-9 |
98% |
Y3297974 |
iRucaparib-AP6 |
2410557-00-3 |
98% |
Y3240936 |
A-192621 |
195529-54-5 |
99% |
Y3304770 |
(rel)-AR234960 |
1408311-94-3 |
99.42% |
Y3238676 |
AS1708727 |
1253226-93-5 |
99% |
Y1253727 |
NCGC00249987 |
1384864-80-5 |
99% |
Y3293971 |
GS-443902 trisodium |
1355050-21-3 |
99% |
Y3306847 |
5-Ethoxy-10-Gingerol |
121771-98-0 |
95% |
Y3259022 |
4''-methyloxy-Genistin |
950910-16-4 |
97% |
Y3252151 |
3'-O-Acetylhamaudol |
30358-88-4 |
99% |
Y3238039 |
Usaramine N-oxide |
117020-54-9 |
99% |
Y3309960 |
Acetylarenobufagin |
184673-79-8 |
98% |
Y1341717 |
Pomalidomide-amido-C1-Br |
2351106-38-0 |
98% |
Y3304797 |
MMAE-SMCC |
2021179-11-1 |
99.56% |
Y3294856 |
Quercetin 3-O-ß-D-(6''-p-coumaroyl)glucopyranosyl(12)-a-L-rhamnopyranoside |
143061-65-8 |
99% |
Y3311679 |
Inz-1 |
897776-15-7 |
98% |
Y3293840 |
N-(3-chloro-4-hydroxyphenyl)-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4,6,8(12),9-pentaene-9-sulfonamide |
397281-20-8 |
99% |
Y3272503 |
Methyl 3-bromo-2-fluoro-6-methoxybenzoate |
1449008-30-3 |
95% |
Y3267223 |
Dimethyl[(3-Bromo-4-methylphenyl)methyl]amine |
1414870-57-7 |
95% |
Y1258007 |
3,4-difluoro-N-{[1-(4-methoxyphenyl)cyclopentyl]methyl}benzamide |
1091474-27-9 |
97% |
Y3286918 |
PROTAC MDM2 Degrader-2 |
2249944-99-6 |
96% |
Y3291859 |
GSK 366 |
1953157-39-5 |
99% |
Y3239739 |
BETd-246 |
2140289-17-2 |
98% |
Y3244282 |
ADU-S100 disodium salt |
1638750-95-4 |
99% |
Y3285860 |
BRD0705 |
2056261-41-5 |
99% |
Y3232046 |
(2R,3R)-E1R |
1400888-63-2 |
98% |
Y1257973 |
HIF-2a-IN-2 |
1672666-82-8 |
98% |
Y3254144 |
SHR0302 |
1445987-21-2 |
98% |
Y3233975 |
MitoTam iodide, hydriodide |
1634624-74-0 |
98% |
Y3268417 |
2-Chloro-5-methylthioanisole |
1394291-30-5 |
95% |
Y3309407 |
Epitheaflagallin 3-O-gallate |
102067-92-5 |
98% |
Y3291487 |
MAC glucuronide linker-1 |
2222981-71-5 |
97% |
Y3310318 |
DB1976 |
1557397-51-9 |
98% |
Y1257946 |
AZD8848 |
866269-28-5 |
98% |
Y3260944 |
Eulophiol |
87402-72-0 |
98.0% |
Y3238835 |
Chloroquine D5 |
1854126-41-2 |
95% |
Y3261848 |
3,4-Difluoro-5-formylphenylboronic acid |
1451393-34-2 |
95% |
Y3297438 |
LY2794193 |
2173037-97-1 |
98% |
Y3236258 |
IZCZ-3 |
2223019-53-0 |
98% |
Y1334026 |
Lenalidomide-acetylene-C5-COOH |
2429878-72-6 |
98% |
Y3237100 |
PROTAC FKBP Degrader-3 |
2079056-43-0 |
99% |
Y1253606 |
Boc-C1-PEG3-C4-OH |
2376724-97-7 |
95% |
Y1253621 |
G0507 |
1223998-29-5 |
98% |
Y3288812 |
Taniborbactam hydrochloride |
2244235-49-0 |
99% |
Y3192145 |
Fructo-oligosaccharide DP10/GF9 |
118150-64-4 |
95% |
Y3313726 |
11-​Oxomogroside III |
952481-53-7 |
98% |
Y1249340 |
Betrixaban D6 |
2098655-51-5 |
98% |
Y3190719 |
(5-Bromo-benzofuran-2-yl)-acetic acid |
84102-74-9 |
95% |
Y1253607 |
Leucocyanidin |
480-17-1 |
98% |
Y3232327 |
Afatinib impurity 11 |
1402086-20-7 |
99% |
Y3234744 |
PROTAC FAK degrader 1 |
2301916-69-6 |
99% |
Y3314594 |
KAG-308 |
1215192-68-9 |
99% |
Y1249306 |
Butin |
21913-99-5 |
98% |
Y3245419 |
N-(4-{8-nitro-2,4-dioxo-3-azatricyclo[7.3.1.0^{5,13}]trideca-1(12),5,7,9(13),10-pentaen-3-yl}phenyl)acetamide |
42340-37-4 |
95% |
Y1258010 |
Saikosaponin B4 |
58558-09-1 |
98% |
Y3252715 |
Isoviolanthin |
40788-84-9 |
97% |
Y3287321 |
Anhydrosecoisolariciresinol |
29388-33-8 |
98% |
Y1249221 |
Ethanone, 2-chloro-1-(4-methoxy-1H-indol-3-yl)- |
858752-72-4 |
97% |
Y3269360 |
7-(3-Ethoxy-3-oxopropyl)-5,5-difluoro-1,3-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide |
1418610-53-3 |
95% |
Y3244748 |
Benzoic acid, 4-[4-(methylthio)phenoxy]- |
21120-66-1 |
91% |
Y3244749 |
[1-(Cyclopropylmethyl)piperidin-4-yl]methanol |
145021-95-0 |
95% |
Y1258011 |
N-Isobutyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide |
1509932-23-3 |
98% |
Y1253693 |
3-Bromo-2,N-dimethyl-benzamide |
1310405-49-2 |
98% |
Y3235024 |
2-Bromo-1-(difluoromethoxy)-3-nitrobenzene |
1174315-54-8 |
95% |
Y1249307 |
VU0529331 |
1286725-49-2 |
99% |
Y3298060 |
ERK1/2 inhibitor 1 |
2095719-90-5 |
99% |
Y3290662 |
Silvestrol aglycone (enantiomer) |
1112993-18-6 |
99% |
Y3294077 |
CL2-SN-38 |
1036969-20-6 |
99% |
Y3292156 |
3a-Hydroxymogrol |
1343402-73-2 |
99% |
Y1249308 |
PROTAC BRD4 ligand-1 |
2313230-51-0 |
97% |
Y3294102 |
K-Ras ligand-Linker Conjugate 4 |
2378261-83-5 |
98% |
Y3290085 |
(2S,3S)-E1R |
1424832-57-4 |
98% |
Y1347669 |
1-(3-Bromo-5-fluorophenyl)ethylamine |
1191908-56-1 |
95% |
Y3237095 |
3-Amino-5-fluoro-N,N-dimethyl-benzamide |
1369862-70-3 |
95% |
Y3245507 |
2-Bromo-1-(2-bromoethoxy)-4-fluorobenzene |
1016879-06-3 |
95% |
Y3238412 |
(4-Amino-3-fluoro-benzyl)-carbamic acid tert-butyl ester |
1823228-30-3 |
95% |
Y3247413 |
1-(2-Trifluoromethyl-benzyl)-1H-pyrazol-4-ol |
1894317-53-3 |
95% |
Y3266230 |
5-Bromo-2-iodophenylacetonitrile |
1055901-15-9 |
98% |
Y3234250 |
2-Chloro-4-phenylpyrimidin-5-amine |
1812201-89-0 |
95% |
Y3245231 |
1-(2-Methyl-benzyl)-1H-pyrazol-4-ol |
1603517-86-7 |
95% |
Y3235083 |
2-Bromo-5-fluoro-4-methoxy-pyrimidine |
1934897-64-9 |
95% |
Y3270923 |
5-Iodo-2,4-dimethyl-1H-imidazole |
631897-38-6 |
95% |
Y3236284 |
1-Butanamine, N-(phenylmethoxy)- |
216237-14-8 |
95% |